Abstract
Disclosed are methods and compositions including polymer-functionalized mammalian mitochondria, useful in a variety of therapeutic regimens for delivery of desirable genetic traits to one or more cells, tissues, and/or organs of interest. Also provided are methods for introducing mitochondria into selected host cells for altering the metabolic phenotype of such host cells using one or more mitochondrially-delivered nucleic acid molecules. The present disclosure is also directed to a method of cellular transplantation, comprising the step of administering to an individual one or more of the polymer functionalized mitochondrial compositions and formulations thereof as described herein.
Original language | English (US) |
---|---|
Patent number | WO2019028469 |
IPC | A61P 35/ 00 A I |
Priority date | 8/4/17 |
State | Published - Feb 7 2019 |